Translational regulation of inhibin βa by TGFβ via the RNA-binding protein hnRNP E1 enhances the invasiveness of epithelial-to-mesenchymal transitioned cells

Oncogene

Volumn 35, Issue 13, 2016, Pages 1725-1735

  Howley, B V ^a,b   Hussey, G S ^a,b   Link, L A ^a,b,c   Howe, P H ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c KENT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HNRNP E1 PROTEIN; HOMODIMER; INHIBIN BETA A; RNA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; INHIBIN; INHIBIN BETA A SUBUNIT; PCBP1 PROTEIN, HUMAN;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSLATION REGULATION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; DRUG EFFECTS; ETHICS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; PROTEIN SYNTHESIS; RNA INTERFERENCE; SCID MOUSE; TRANSGENIC MOUSE; TUMOR INVASION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; INHIBIN-BETA SUBUNITS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84932080470     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.238     Document Type: Article

References (32)

1. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-4326.
2. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
3. Massagué J, Blain SW, Lo RS. TGF signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
4. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145: 926-940.
5. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
6. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-[beta]-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 2010; 12: 286-293.
7. Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MC et al. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 2011; 41: 419-431.
8. Hussey GS, Link LA, Brown AS, Howley BV, Chaudhury A, Howe PH. Establishment of a TGF-induced post-transcriptional EMT gene signature. PLoS One 2012; 7: e52624.
9. Li R, Phillips DM, Mather JP. Activin promotes ovarian follicle development in vitro. Endocrinology 1995; 136: 849-856.
10. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R et al. Functional analysis of activins during mammalian development. Nature 1995; 374: 354-357.
11. Ogawa Y, Schmidt DK, Nathan RM, Armstrong RM, Miller KL, Sawamura SJ et al. Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J Biol Chem 1992; 267: 14233-14237.
12. Pearson S, Sroczynska P, Lacaud G, Kouskoff V. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 2008; 135: 1525-1535.
13. Schmierer B, Hill CS. TGF[beta]-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970-982.
14. Le Bras GF, Loomans HA, Taylor CJ, Revetta FL, Andl CD. Activin A balance regulates epithelial invasiveness and tumorigenesis. Lab Invest 2014; 94: 1134-1146.
15. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK. Activin A mediates growth inhibition and cell cycle arrest through smads in human breast cancer cells. Cancer Res 2005; 65: 7968-7975.
16. Lonardo E, Hermann PC, Mueller MT, Huber S, Balic A, Miranda-Lorenzo I et al. Nodal/activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 2011; 9: 433-446.
17. Reis FM, Cobellis L, Tameiraõ LC, Anania G, Luisi S, Silva ISB et al. Serum and tissue expression of activin A in postmenopausal women with breast cancer. J Clin Endocrinol Metab 2002; 87: 2277-2282.
18. Wildi S, Kleeff J, Maruyama H, Maurer CA, Büchler MW, Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut 2001; 49: 409-417.
19. Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan DW et al. Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol 2012; 29: 77-83.
20. Leto G, Incorvaia L, Badalamenti G, Tumminello F, Gebbia N, Flandina C et al. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin Exp Metastasis 2006; 23: 117-122.
21. Kang HY, Huang HY, Hsieh CY, Li CF, Shyr CR, Tsai MY et al. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer. J Bone Miner Res 2009; 24: 1180-1193.
22. Kim H, Watkinson J, Varadan V, Anastassiou D. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 2010; 3: 51.
23. Antenos M, Stemler M, Boime I, Woodruff TK. N-linked oligosaccharides direct the differential assembly and secretion of inhibin-and A-subunit dimers. Mol Endocrinol 2007; 21: 1670-1684.
24. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999; 112: 4557-4568.
25. Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 2012; 31: 469-478.
26. Arai KY, Ono M, Kudo C, Fujioka A, Okamura R, Nomura Y et al. IL-1 stimulates activin A mRNA expression in human skin fibroblasts through the MAPK pathways, the nuclear factor-B pathway, and prostaglandin E2. Endocrinology 2011; 152: 3779-3790.
27. Wamsley JJ, Kumar M, Allison DF, Clift SH, Holzknecht CM, Szymura SJ et al. Activin upregulation by NF-B is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer. Cancer Res 2014; 75: 426-435.
28. Valcourt U, Kowanetz M, Niimi H, Heldin C-H, Moustakas A. TGF-and the smad signaling pathway support transcriptomic reprogramming during epithelialmesenchymal cell transition. Mol Biol Cell 2005; 16: 1987-2002.
29. Lee KL, Lim SK, Orlov YL, Yit LY, Yang H, Ang LT et al. Graded nodal/activin signaling titrates conversion of quantitative phospho-smad2 levels into qualitative embryonic stem cell fate decisions. PLoS Genet 2011; 7: e1002130.
30. Kim ES, Kim MS, Moon A. Transforming growth factor (TGF)-in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 2005; 29: 84-91.
31. Seder CW, Hartojo W, Lin L, Silvers AL, Wang Z, Thomas DG et al. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia 2009; 11: 388-396.
32. Walia V, Elble RC. Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion. Stem Cells Dev 2010; 19: 1175-1182.